FR2293935B1 - - Google Patents

Info

Publication number
FR2293935B1
FR2293935B1 FR7538212A FR7538212A FR2293935B1 FR 2293935 B1 FR2293935 B1 FR 2293935B1 FR 7538212 A FR7538212 A FR 7538212A FR 7538212 A FR7538212 A FR 7538212A FR 2293935 B1 FR2293935 B1 FR 2293935B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7538212A
Other languages
French (fr)
Other versions
FR2293935A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2293935A1 publication Critical patent/FR2293935A1/fr
Application granted granted Critical
Publication of FR2293935B1 publication Critical patent/FR2293935B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
FR7538212A 1974-12-13 1975-12-12 3-(thio substitue) cephalosporines antibiotiques Granted FR2293935A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/532,431 US3992377A (en) 1974-12-13 1974-12-13 3-Thio-substituted cephalosporin antibiotics

Publications (2)

Publication Number Publication Date
FR2293935A1 FR2293935A1 (fr) 1976-07-09
FR2293935B1 true FR2293935B1 (US20050192411A1-20050901-C00001.png) 1979-09-21

Family

ID=24121771

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7538212A Granted FR2293935A1 (fr) 1974-12-13 1975-12-12 3-(thio substitue) cephalosporines antibiotiques

Country Status (11)

Country Link
US (1) US3992377A (US20050192411A1-20050901-C00001.png)
JP (1) JPS5182292A (US20050192411A1-20050901-C00001.png)
BE (1) BE836565A (US20050192411A1-20050901-C00001.png)
CA (1) CA1039270A (US20050192411A1-20050901-C00001.png)
CH (1) CH620216A5 (US20050192411A1-20050901-C00001.png)
DE (1) DE2555858A1 (US20050192411A1-20050901-C00001.png)
FR (1) FR2293935A1 (US20050192411A1-20050901-C00001.png)
GB (1) GB1526978A (US20050192411A1-20050901-C00001.png)
IE (1) IE41918B1 (US20050192411A1-20050901-C00001.png)
IL (1) IL48341A (US20050192411A1-20050901-C00001.png)
NL (1) NL7514557A (US20050192411A1-20050901-C00001.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605997A5 (US20050192411A1-20050901-C00001.png) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US4150156A (en) * 1975-11-21 1979-04-17 Merck & Co., Inc. 7-(Substituted methyl)-3-(substituted thio)-cephalosporins, derivatives and pharmaceutical compositions containing them
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
US4197402A (en) * 1976-08-09 1980-04-08 Shionogi & Co., Ltd. Cephalosporin analogues
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
FR2418233A2 (fr) * 1978-02-22 1979-09-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkylthio ou 3-acylamino 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4739048A (en) * 1980-05-29 1988-04-19 Merck & Co., Inc. Process for the preparation of thienamycin and intermediates
US4745188A (en) * 1980-11-21 1988-05-17 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
GR76342B (US20050192411A1-20050901-C00001.png) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co
JPS5984890A (ja) 1982-11-05 1984-05-16 Hisayasu Ishimaru 経口用セフアロスポリン化合物
FR2550200B1 (fr) * 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
JPH0686459B2 (ja) * 1989-12-07 1994-11-02 明治製菓株式会社 3―置換チオ―3―セフエム化合物の製造法
JP2857532B2 (ja) * 1992-03-12 1999-02-17 明治製菓株式会社 新規セファロスポリン誘導体
US5698547A (en) * 1994-04-01 1997-12-16 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US5688786A (en) * 1994-04-01 1997-11-18 Microcide Pharmaceuticals, Inc. β-lactam antibiotics
LT4193B (en) 1994-04-01 1997-07-25 Microcide Pharmaceuticals Inc Cephalosporin antibiotics
US5789584A (en) * 1994-04-01 1998-08-04 Microcide Pharmaceuticals, Inc. Substituted-pyridinyl cephalosporin antibiotics active against methicillin resistant bacteria
US5551306A (en) * 1994-12-06 1996-09-03 Hersey Measurement Company Magnetic flowmeter
WO1996017850A1 (en) * 1994-12-09 1996-06-13 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and pharmaceutical use thereof
WO1996038450A1 (en) * 1995-05-31 1996-12-05 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
AUPN801196A0 (en) * 1996-02-12 1996-03-07 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and pharmaceutical use thereof
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
CH620216A5 (US20050192411A1-20050901-C00001.png) 1980-11-14
NL7514557A (nl) 1976-06-15
JPS5182292A (en) 1976-07-19
IE41918L (en) 1976-06-13
FR2293935A1 (fr) 1976-07-09
GB1526978A (en) 1978-10-04
BE836565A (fr) 1976-06-11
CA1039270A (en) 1978-09-26
IL48341A (en) 1980-05-30
US3992377A (en) 1976-11-16
DE2555858A1 (de) 1976-06-16
IE41918B1 (en) 1980-04-23
IL48341A0 (en) 1975-12-31

Similar Documents

Publication Publication Date Title
FR2272785A1 (US20050192411A1-20050901-C00001.png)
FR2282895B1 (US20050192411A1-20050901-C00001.png)
FR2293935B1 (US20050192411A1-20050901-C00001.png)
FR2291391B3 (US20050192411A1-20050901-C00001.png)
FR2289753B1 (US20050192411A1-20050901-C00001.png)
FR2290485B1 (US20050192411A1-20050901-C00001.png)
JPS50132733A (US20050192411A1-20050901-C00001.png)
JPS50136403A (US20050192411A1-20050901-C00001.png)
JPS50116606A (US20050192411A1-20050901-C00001.png)
AU495028B2 (US20050192411A1-20050901-C00001.png)
AR198841Q (US20050192411A1-20050901-C00001.png)
JPS50131911U (US20050192411A1-20050901-C00001.png)
JPS50120436U (US20050192411A1-20050901-C00001.png)
JPS50123794A (US20050192411A1-20050901-C00001.png)
JPS50127148A (US20050192411A1-20050901-C00001.png)
JPS50107530U (US20050192411A1-20050901-C00001.png)
BG19639A1 (US20050192411A1-20050901-C00001.png)
BE836964A (US20050192411A1-20050901-C00001.png)
BG20447A1 (US20050192411A1-20050901-C00001.png)
BG20459A1 (US20050192411A1-20050901-C00001.png)
CH575605A5 (US20050192411A1-20050901-C00001.png)
CH576591A5 (US20050192411A1-20050901-C00001.png)
BG20643A1 (US20050192411A1-20050901-C00001.png)
BG20852A1 (US20050192411A1-20050901-C00001.png)
BG22566A1 (US20050192411A1-20050901-C00001.png)

Legal Events

Date Code Title Description
ST Notification of lapse